These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 3146444

  • 1. Complete estrogen blockade with buserelin and aminoglutethimide for advanced breast cancer: a phase I-II study with long-term hormonal correlations.
    Ferrari V, Zaniboni A, Simoncini E, Marpicati E, Montini E, Moretti R, Marini G.
    Chemioterapia; 1988 Dec; 7(6):414-9. PubMed ID: 3146444
    [Abstract] [Full Text] [Related]

  • 2. [Buserelin therapy in postmenopausal patients with advanced breast carcinoma].
    Vici P, Veltri E, Carpano S, Di Lauro L, Lopez M.
    Clin Ter; 1991 Feb 15; 136(3):195-9. PubMed ID: 1827382
    [Abstract] [Full Text] [Related]

  • 3. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.
    Goss PE, Clark RM, Ambus U, Weizel HA, Wadden NA, Crump M, Walde D, Tye LM, De Coster R, Bruynseels J.
    Clin Cancer Res; 1995 Mar 15; 1(3):287-94. PubMed ID: 9815984
    [Abstract] [Full Text] [Related]

  • 4. Aminoglutethimide without hydrocortisone in the treatment of postmenopausal patients with advanced breast cancer.
    Höffken K, Kempf H, Miller AA, Miller B, Schmidt CG, Faber P, Kley HK.
    Cancer Treat Rep; 1986 Oct 15; 70(10):1153-7. PubMed ID: 3756937
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment of advanced cancer of the prostate with an analog of LHRH, buserelin].
    Wenderoth UK, Jacobi GH.
    Ann Urol (Paris); 1986 Oct 15; 20(2):95-7. PubMed ID: 3087269
    [Abstract] [Full Text] [Related]

  • 8. Influence of LH-RH agonists on the growth and hormonal environment of breast and prostate cancer.
    Nicholson RI, Walker KJ.
    Chemioterapia; 1985 Jun 15; 4(3):249-51. PubMed ID: 3161643
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer.
    Williams MR, Walker KJ, Turkes A, Blamey RW, Nicholson RI.
    Br J Cancer; 1986 May 15; 53(5):629-36. PubMed ID: 2941044
    [Abstract] [Full Text] [Related]

  • 11. [Aminoglutethimide in advanced breast cancer. Multicenter trial comparing 500 mg and 1000 mg per day].
    Bonneterre J, Coppens H, Mauriac L, Rouesse J, Fargeot P, Metz R, Armand JP, Mathieu A, Tubiana M, Cappelaere P.
    Acta Clin Belg Suppl; 1986 May 15; 11():41-8. PubMed ID: 3521171
    [No Abstract] [Full Text] [Related]

  • 12. Premenopausal breast cancer patients treated with a gonadotropin-releasing hormone analog alone or in combination with an aromatase inhibitor: a comparative endocrine study.
    Celio L, Martinetti A, Ferrari L, Buzzoni R, Mariani L, Miceli R, Seregni E, Procopio G, Cassata A, Bombardieri E, Bajetta E.
    Anticancer Res; 1999 May 15; 19(3B):2261-8. PubMed ID: 10472341
    [Abstract] [Full Text] [Related]

  • 13. Phase II study of aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer.
    Nagel GA, Wander HE, Blossey HC.
    Cancer Res; 1982 Aug 15; 42(8 Suppl):3442s-3444s. PubMed ID: 6123383
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Aminoglutethimide in advanced breast cancer: prospective, randomized comparison of two dose levels. Italian Cooperative Group.
    Robustelli della Cuna G, Pannuti F, Martoni A, Camaggi CM, Strocchi E, Da Prada GA, Tanneberger S.
    Anticancer Res; 1993 Aug 15; 13(6B):2367-71. PubMed ID: 8135469
    [Abstract] [Full Text] [Related]

  • 18. Aminoglutethimide in the treatment of advanced postmenopausal breast cancer.
    Harris AL, Powles TJ, Smith IE.
    Cancer Res; 1982 Aug 15; 42(8 Suppl):3405s-3408s. PubMed ID: 7083207
    [Abstract] [Full Text] [Related]

  • 19. Use of aminoglutethimide for the treatment of advanced breast cancer. Clinical correlations with previous treatment, oestrogen-receptor and menstrual status.
    Bezwoda WR, Dansey RD, Hesdorffer CS, Browde S.
    S Afr Med J; 1987 Jul 18; 72(2):107-9. PubMed ID: 3616780
    [Abstract] [Full Text] [Related]

  • 20. Advanced male breast cancer treatment with the LH-RH analogue buserelin alone or in combination with the antiandrogen flutamide.
    Doberauer C, Niederle N, Schmidt CG.
    Cancer; 1988 Aug 01; 62(3):474-8. PubMed ID: 3134119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.